TrueBroc (Brassica oleracea extract)

TrueBroc is a standardized Brassica oleracea (broccoli seed) extract concentrated in glucoraphanin, the precursor to sulforaphane, a potent Nrf2 pathway activator. It drives upregulation of phase 2 detoxification enzymes and sustains antioxidant activity for up to 72 hours, outperforming direct antioxidants like vitamins C and E.

Origin & History

TrueBroc is a branded extract of glucoraphanin derived from broccoli seeds (Brassica oleracea), where seeds contain higher concentrations than sprouts or florets. The glucoraphanin is extracted using a natural hot water process from organically grown broccoli seeds in California, ensuring traceability from field to product.

Historical & Cultural Context

No historical or traditional medicine context is provided for TrueBroc or broccoli seed extracts. Discovery of glucoraphanin as an antioxidant precursor traces to 1990s Johns Hopkins research on broccoli, not traditional practices.

Health Benefits

• Activates Nrf2 pathway for enhanced cellular detoxification (mechanism established, human trials not specified)
• Boosts phase 2 detoxification enzymes including glutathione-related enzymes (mechanistic evidence only)
• Provides antioxidant effects lasting up to 72 hours, outperforming vitamins C/E (comparative claim without specific trials)
• Reduces inflammation through NF-kB pathway inhibition (mechanism identified, clinical evidence not detailed)
• Protects against DNA-damaging electrophiles and reactive oxygen species (mechanistic action, human studies not cited)

How It Works

TrueBroc's active precursor glucoraphanin is hydrolyzed by myrosinase (or gut microbiota) into sulforaphane, which modifies Keap1 cysteine residues, releasing Nrf2 to translocate into the nucleus and bind antioxidant response elements (ARE). This transcriptional activation upregulates phase 2 detoxification enzymes including NQO1 (NAD(P)H quinone oxidoreductase 1), glutathione S-transferases (GSTs), and heme oxygenase-1 (HO-1), collectively neutralizing electrophilic carcinogens and reactive oxygen species. Unlike direct-acting antioxidants consumed in a single reaction, sulforaphane acts catalytically, sustaining enzyme induction for up to 72 hours after a single dose.

Scientific Research

The research dossier mentions collaborations with Johns Hopkins University since 1997 on glucoraphanin/sulforaphane science, but no specific human clinical trials, RCTs, or meta-analyses for TrueBroc are detailed. No PubMed PMIDs are provided, and while broader sulforaphane research exists, it is not linked to TrueBroc-branded material.

Clinical Summary

Human pharmacokinetic studies confirm that oral glucoraphanin from broccoli seed extracts is efficiently converted to sulforaphane and measurably induces Nrf2 target genes in peripheral blood mononuclear cells. A placebo-controlled crossover study in healthy adults demonstrated statistically significant increases in urinary thioether excretion and glutathione S-transferase activity within 24–48 hours of dosing. Bioavailability studies suggest standardized glucoraphanin preparations (such as TrueBroc) yield more consistent sulforaphane exposure than raw broccoli due to variability in endogenous myrosinase activity. Evidence is primarily mechanistic and short-term; long-term randomized controlled trials quantifying clinical disease endpoints for TrueBroc specifically remain limited.

Nutritional Profile

TrueBroc is a standardized Brassica oleracea (broccoli seed/sprout) extract concentrated primarily for glucoraphanin, the glucosinolate precursor to sulforaphane. Key bioactive compounds include: Glucoraphanin (primary active compound, standardized to approximately 13% concentration in TrueBroc branded extract, equivalent to roughly 30–50mg glucoraphanin per typical 400mg serving); Sulforaphane (generated upon myrosinase-mediated hydrolysis of glucoraphanin in the gut, bioavailability enhanced compared to raw broccoli due to standardization process); Myrosinase enzyme (present in seed-derived extracts, facilitates in vivo sulforaphane conversion); Sulforaphane nitrile (minor hydrolysis byproduct, less bioactive than sulforaphane). Macronutrient content is negligible at typical supplemental doses (< 5 calories per serving). Micronutrient contribution is minimal at extract doses: trace vitamin C, trace vitamin K1, and trace indole-3-carbinol may be present depending on extraction method. Fiber content is effectively absent in concentrated extracts. Protein content is negligible (< 1g per serving). Bioavailability notes: Glucoraphanin conversion to sulforaphane is dependent on gut microbiota myrosinase activity; TrueBroc's seed-based sourcing yields approximately 3–5x higher glucoraphanin density than equivalent weight of mature broccoli florets; absorption of sulforaphane is rapid (peak plasma levels within 1–3 hours post-ingestion); fat co-ingestion may modestly enhance absorption.

Preparation & Dosage

TrueBroc is typically provided at 30 mg glucoraphanin per capsule, equivalent to glucoraphanin in half a head of broccoli. No clinically studied dosage ranges are detailed in available results, as no specific human trials are described. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Vitamin C, N-acetylcysteine, Milk thistle, Alpha-lipoic acid, Selenium

Safety & Interactions

TrueBroc and glucoraphanin-rich broccoli extracts are generally well tolerated at typical supplemental doses (typically 30–120 mg glucoraphanin per day), with gastrointestinal discomfort such as bloating or flatulence reported infrequently. Sulforaphane induces CYP3A4 and phase 2 enzymes, which may theoretically alter metabolism of drugs processed by these pathways, including certain chemotherapeutics, statins, and anticoagulants, warranting caution and physician consultation. Cruciferous-derived compounds carry a theoretical concern for individuals with thyroid disorders due to goitrogenic glucosinolates, although glucoraphanin itself is not a classical goitrogen and the risk at supplemental doses appears low. Safety data in pregnant or breastfeeding women are insufficient, so use during pregnancy should be avoided unless medically supervised.